Triamcinolone Acetonide Tablets
0.5 mg, 1000/Bottle
BOEHRINGER INGELHEIM 136106

Product Description

Triamcinolone Acetonide Tablets
0.5 mg, 1000/Bottle
BOEHRINGER INGELHEIM 136106
1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE.
2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( VET OFFICES , PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE.
3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )
Specifications
Active Ingredient:
Triamcinolone Acetonide
Color Of Medicine:
Light Pink
Package Quantity:
1000/Bottle
Strength:
0.5 mg
Presentation:
Tablet
Pill Count:
1000
Container Type:
Bottle
Delivery Type:
Oral
Reconstitution Required:
N
Product Details
(Triamcinolone Acetonide)
Indicated in the management and treatment of acute arthritis and allergic and dermatologic disorders. Features:
Few sodium-retaining effects
Equal anti-inflammatory effects
Treat-to-effect dosage
Highly potent synthetic glucocorticoid and anti-flammatory agent for treatment of inflammation and related disorders in cats and dogs
Benefits:
Less water retention
Comparable anti-flammatory effects as older corticosteroids with a lower dose
After initial suppressive dose level has been administered and satisfactory response obtained, the daily dose can be reduced to the minimal effective maintenance dose level